Abstract
Aim: This study co-evaluated the 2 quoted histologic variables after erythropoietin (Epo) administration. The calculation was based on the results of 2 preliminary studies, each one evaluating a respective histologic variable of endometrial karyorrhexis (EK) or uterus congestion (UC) in an induced ischemia reperfusion (IR) animal experiment.
Highlights
Erythropoietin (Epo) was investigated whether having antioxidant capacities. 2 histologic variables in a uterine ischemia reperfusion (UIR) experiment were tested for this purpose
The one variable was that of endometrial karyorrhexis (EK) which was recessed by without lesions 0.2727273 ± 0.17222171 (p-value=0.1102) [1]
TLR4 has a regulatory role for two antiinflammatory cytokines: the interferon-B1 decreased in wildtype mice and the interleukin-10 increased in TLR4-deficient mice (P
Summary
Erythropoietin (Epo) was investigated whether having antioxidant capacities. 2 histologic variables in a uterine ischemia reperfusion (UIR) experiment were tested for this purpose. Erythropoietin (Epo) was investigated whether having antioxidant capacities. 2 histologic variables in a uterine ischemia reperfusion (UIR) experiment were tested for this purpose. The one variable was that of endometrial karyorrhexis (EK) which was recessed by without lesions 0.2727273 ± 0.17222171 (p-value=0.1102) [1]. The other variable was that of uterus congestion (UC) and was restored by without lesions 0.0090909 ± 0.12689199 (p-value=0.9414) [2]. Epo is met in over 29,895 published biomedical studies, only a 3.51% of them negotiate its antioxidant capacities. The present experimental work tried to co-evaluate these EK and UC variables together and to compare its outcome with each one separately, from the same rat induced UIR protocol
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Network Medicine and Targeted Therapies
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
